Head-to-head · WeighScore
Bodi Envi vs ReadyRx
The verdict
Bodi Envi takes it — 71.8/100 to 67.8/100.
Bodi Envi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bodi Envi is a nationwide telehealth weight-loss provider offering physician-prescribed compounded semaglutide ($179/month) and tirzepatide ($249/month) at flat all-dose pricing with no consultation or…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Bodi Envi | ReadyRx |
|---|---|---|
| WeighScore | 71.8/100 | 67.8/100 |
| Grade | C | C |
| Scorecard rank | #88 | #156 |
| Semaglutide | $179/mo | $179/mo (starting dose, compounded) |
| Tirzepatide | $249/mo | $255/mo (starting dose, compounded) |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #88 · C
Strengths
- Transparent flat pricing: compounded semaglutide $179/month and tirzepatide $249/month, all doses
- No consultation or membership fees
- Free 2-day shipping included; FSA and HSA eligible
- 24/7 secure provider messaging with same-day visits and prescriptions
- Personalized dose titration with side-effect management (Zofran available)
Where it loses points
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
- No insurance billing — cash-pay only
- States served are not explicitly listed (features vary by state)
- No LegitScript certification visible on the site
Graded #156 · C
Strengths
- LegitScript Certified — verifiable via the badge link in the footer
- Batch lab testing covers the right QA metrics for injectables: potency, sterility, pH, and endotoxicity
- Pricing shown publicly: $179/mo semaglutide, $255/mo tirzepatide
Where it loses points
- Pharmacy partners not named — only described as 'FDA-registered compounding pharmacies'
- Clinicians described as licensed and board-certified, but no names or credentials published
- 5,000+ member figure comes from a directory listing, not an independent audit
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.